Articles scientifiques

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.

Auteurs : Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, Van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M
Année : 2021
Journal : Ann Oncol
Volume : 32
Pages : 1332-1347

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.

Auteurs : Agostinetto E, Eiger D, Lambertini M, Ceppi M, Bruzzone M, Pondé N, Plummer C, Awada A, Santoro A, Piccart-Gebhart M, de Azambuja E
Année : 2021
Journal : Eur J Cancer
Volume : 148
Pages : 76-91

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.

Auteurs : Franzoi MA, Agostinetto E, Perachino M, Del Mastro L, de Azambuja E, Vaz-Luis I, Partridge AH, Lambertini M
Année : 2021
Journal : Lancet Oncol
Volume : 22
Pages : e303-e313

Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer Center.

Auteurs : Olympios N, Collet L, Paesmans M, Jungels C, Kotecki N, Awada A, Aftimos P
Année : 2021
Journal : Oncologist
Volume : 26
Pages : 1062-1070

CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer.

Auteurs : Agostinetto E, Debien V, Marta GN, Lambertini M, Piccart-Gebhart M, de Azambuja E
Année : 2021
Journal : Eur J Clin Invest
Pages : e13535

The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.

Auteurs : Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V
Année : 2020
Journal : World J Surg Oncol
Volume : 18
Pages : 106

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer.

Auteurs : Krop I, Abramson V, Colleoni M, Traina T, Holmes F, Garcia-Estevez L, Hart L, Awada A, Zamagni C, Morris PG, Schwartzberg L, Chan S, Gucalp A, Biganzoli L, Steinberg J, Sica L, Trudeau M, Markova D, Tarazi J, Zhu Z, OBrien T, Kelly CM, Winer E, Yardley DA
Année : 2020
Journal : Clin Cancer Res
Volume : 26
Pages : 6149-6157

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method.

Auteurs : Cuyle PJ, Geboes K, Carton S, Casneuf V, Decaestecker J, De Man M, Demolin G, Deroose CM, De Vleeschouwer C, Flamen P, Hendlisz A, Hoorens A, Janssens J, Karfis I, Lybaert W, Machiels G, Monsaert E, Sinapi I, van Cutsem E, Vandamme T, Borbath I, Verslype C
Année : 2020
Journal : Acta Gastroenterol Belg
Volume : 83
Pages : 643-653

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.

Auteurs : Fontana E, Nyamundanda G, Cunningham D, Tu D, Cheang MCU, Jonker DJ, Siu LL, Sclafani F, Eason K, Ragulan C, Bali MA, Hulkki-Wilson S, Loree JM, Waring PM, Giordano M, Lawrence P, Rodrigues DN, Begum R, Shapiro JD, Price TJ, Cremolini C, Starling N, Pietrantonio F, Trusolino L, OCallaghan CJ, Sadanandam A
Année : 2020
Journal : JCO Precis Oncol
Volume : 4

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity.

Auteurs : Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A
Année : 2020
Journal : ESMO Open
Volume : 5

Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.

Auteurs : Mierzynska J, Taye M, Pe M, Coens C, Martinelli F, Pogoda K, Velikova G, Bjelic-Radisic V, Cardoso F, Brain E, Ignatiadis M, Piccart-Gebhart M, Van Tienhoven G, Mansel R, Wildiers H, Bottomley A
Année : 2020
Journal : Eur J Cancer
Volume : 125
Pages : 69-82

Targeted therapy for breast cancer in older patients.

Auteurs : Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Dal Lago L
Année : 2020
Journal : J Geriatr Oncol
Volume : 11
Pages : 380-388

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.

Auteurs : Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F
Année : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pages : 1438-1446

Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

Auteurs : Albisinni S, Aoun F, Diamand R, Mjaess G, Esperto F, Martinez Chanza N, Roumeguère T, DE Nunzio C
Année : 2020
Journal : Minerva Urol Nefrol
Volume : 72
Pages : 663-672

Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.

Auteurs : Sclafani F, Hendlisz A
Année : 2020
Journal : Curr Opin Oncol

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Auteurs : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Année : 2020
Journal : J Visc Surg
Volume : 157
Pages : 79-86

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

Auteurs : Gómez-Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernández-Jiménez E, Maetens M, Salgado R, Zafeiroglou M, Pellegrini P, Venet D, Garaud S, Trinidad EM, Benítez S, Vuylsteke P, Polastro L, Wildiers H, Simon P, Lindeman G, Larsimont D, Van den Eynden G, Velghe C, Rothé F, Willard-Gallo K, Michiels S, Muñoz P, Walzer T, Planelles L, Penninger J, Azim HA Jr, Loi S, Piccart-Gebhart M, Sotiriou C, González-Suárez E
Année : 2020
Journal : Nat Commun
Volume : 11
Pages : 6335

Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results.

Auteurs : Catala G, Mebis J, Jerusalem G, Verhoeven D, Awada A, Bols A, Somers L, Van Den Broeck A, Duhoux FP, Machiels JP
Année : 2020
Journal : Acta Clin Belg
Volume : 75
Pages : 128-135

Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics.

Auteurs : Fares JE, El Tomb P, Khalil LE, Atwani RW, Moukadem HA, Awada A, El Saghir NS
Année : 2020
Journal : Cancer Treat Rev
Volume : 89
Pages : 102066

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Auteurs : Eiger D, Wagner M, Pondé NF, Nogueira MS, Buisseret L, de Azambuja E
Année : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pages : 723-725